Intranasal GDNF for Parkinson's Disease: Next steps in preclinical development

被引：0
|
作者：
Waszczak, Barbara Lee [1 ]
Wachtman, Lynn [2 ]
Newsome, Ginnifer C. [2 ]
Aly, Amirah [1 ]
Silva, Nilsa [2 ]
Westmoreland, Susan [2 ]
Rowlett, James [2 ]
Migliore, Mattia M. [3 ]
机构：
[1] Northeastern Univ, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA
[3] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1177.10
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The potential of GDNF as a treatment for Parkinson's disease - Commentary
    Hurelbrink, CB
    Barker, RA
    EXPERIMENTAL NEUROLOGY, 2004, 185 (01) : 1 - 6
  • [22] Intraventricular administration of GDNF in the treatment of Parkinson's disease
    Nutt, JG
    Bronstein, JM
    Carter, JH
    Comella, CL
    Cravets, M
    Davis, TL
    Jankovic, J
    Klein, M
    Koller, WC
    Lang, AE
    Lee, DR
    O'Brien, CF
    Pahwa, R
    Schultz, B
    Siemers, ER
    Stacy, M
    Thomas-Lukes, K
    Trugman, JM
    Tuite, PJ
    Weiner, WJ
    Wooten, GF
    NEUROLOGY, 2001, 56 (08) : A375 - A375
  • [23] GDNF trial: promising results for Parkinson's disease
    Butcher, J
    LANCET NEUROLOGY, 2003, 2 (05): : 265 - 265
  • [24] Preclinical (premotor) Parkinson’s disease
    E. Ch. Wolters
    C. Francot
    P. Bergmans
    A. Winogrodzka
    J. Booij
    H. W. Berendse
    J. C. Stoof
    Journal of Neurology, 2000, 247 (Suppl 2) : 103 - 109
  • [25] Preclinical diagnosis of Parkinson's disease
    Oertel, W. H.
    Eggert, K. M.
    Moeller, C. J.
    Mayer, T. J. J. Geert
    Behlke, M.
    Knake, S.
    Unger, M. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 7 - 7
  • [26] Preclinical (premotor) Parkinson's disease
    Wolters, EC
    Francot, C
    Bergmans, P
    Winogrodzka, A
    Booij, J
    Berendse, HW
    Stoof, JC
    JOURNAL OF NEUROLOGY, 2000, 247 : 103 - 109
  • [27] Is GDNF beneficial in Parkinson disease?
    Barry J. Hoffer
    Brandon K. Harvey
    Nature Reviews Neurology, 2011, 7 : 600 - 602
  • [28] COMPARATIVE STUDY OF THE NEUROTROPHIC EFFECTS ELICITED BY VEGF-B AND GDNF IN PRECLINICAL IN VIVO MODELS OF PARKINSON'S DISEASE
    Yue, X.
    Hariri, D. J.
    Caballero, B.
    Zhang, S.
    Bartlett, M. J.
    Kaut, O.
    Mount, D. W.
    Wuellner, U.
    Sherman, S. J.
    Falk, T.
    NEUROSCIENCE, 2014, 258 : 385 - 400
  • [29] Sustained delivery of GDNF: towards a treatment for Parkinson's disease
    Zurn, AD
    Widmer, HR
    Aebischer, P
    BRAIN RESEARCH REVIEWS, 2001, 36 (2-3) : 222 - 229
  • [30] The next steps in curing Alzheimer's disease
    van Leeuwen, Fred W.
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 219 - 221
12345